Category: CLABSI

Advancing the Culture of Patient Safety: Strategies to Prevent CLABSI and CAUTI

Prepared by IPRO HQIC

Hospital-Acquired Infections (HAIs) are among the most common complications in hospitals and continue to be a significant concern in the healthcare system. The Agency for Healthcare Research and Quality estimates that approximately 633,300 patients contract one of these infections annually, costing billions for healthcare organizations. These infections can lead to significant morbidity and mortality, with tens of thousands of lives lost each year.

To improve the overall quality of care, it is important that healthcare professionals direct their focus toward identifying and creating opportunities for improving performance and outcomes. In this Lunch & Learn we will cover:

  • The prevalence of Central Line Associated Blood Stream Infection (CLABSI) and Catheter-Associated Urinary Tract Infection (CAUTI).
  • The causative factors and evidence-based strategies for CLABSI and CAUTI prevention.
  • How the Appalachian Regional Healthcare System successfully implemented evidence-based strategies that resulted in a significant decrease in CLABSI and CAUTI rates.

April 18, 2023 LAN Event – Using TAP Strategy for HAI Reduction: CAUTI, CLABSI, C. diff, MRSA

Prepared by IPRO HQIC

Join us for a webinar featuring subject matter experts from the Centers for Disease Control and Prevention (CDC) to learn about a comprehensive strategy to reduce hospital acquired infections (HAI). The Targeted Assessment for Prevention (TAP) Strategy is a CDC-developed framework for quality improvement that uses data to drive interventions that will prevent healthcare-associated infections. The TAP strategy targets healthcare facilities and specific units within facilities that have a disproportionate burden of HAIs so that prevention efforts can be prioritized and implemented where they will have the greatest impact. Our speakers will discuss the latest updates in the strategy and tools, including adaptation for smaller facilities.

Moving Forward Using Lessons Learned to Prevent Central Line-Associated Bloodstream Infections (CLABSI) June 23, 2022 – Part 2 of the 5-part Joint HQIC ‘Preventing Healthcare Associated Infections’ Learning & Action Network Series.

Prepared by IPRO HQIC

Preventing CLABSI remains a national patient safety priority given its associated harms of increased hospital length of stay, costs, morbidity and a 12–25 percent mortality rate. Recent studies have shown that during the COVID-19 pandemic, many hospitals experienced a significant increase in their CLABSI rates. This dynamic webinar features proactive strategies and tools for preventing all-cause harm related to CLABSI and showcases a hospital’s success with engaging leaders, providers and front-line staff in a hospital-wide initiative to drive down device utilization, increase bundle compliance and improve outcomes.

Toolkit for Decolonization of Non-ICU Patients with Devices

Prepared by the Agency for Healthcare Research and Quality (AHRQ)

This toolkit will provide hospital infection prevention programs with instructions for implementing targeted decolonization in adult patients with medical devices in hospital units outside of intensive care (i.e., non-ICUs).

Patient Safety Analysis Quick Reference Guides

Centers for Disease Control and Prevention

These quick reference guides were created to help you understand, modify, and interpret your data using the NHSN application’s various analysis output (report) options for the NHSN Patient Safety Component. These guides serve as companions to the “Introduction to NHSN Analysis” training slide set.

National Healthcare Safety Network (NHSN)Patient Safety Analysis Resource

Centers for Disease Control and Prevention

The NHSN application provides various options that allow NHSN users to analyze their surveillance data. The resources listed on the link above are intended to help you use the analysis tool, and interpret data analyzed from the Patient Safety Component of NHSN.

Building a Team to Reduce CLABSI and CAUTI

Prepared by the HAP Quality Initiatives Department
Healthcare Associated Infection Prevention Managers
September 2019 for IPRO HQIC

The purpose of this tool kit is to teach you the key elements that are essential in building a successful team to reduce central line associated bloodstream infections (CLABSI) and catheter associated urinary tract infections (CAUTI) on your unit. The tool kit will provide you with information on how to develop a team, assess your work practices, develop an action plan, implement changes, and evaluate your success.

2021 NHSN Training videos

Centers for Disease Control (CDC), National Healthcare Safety Network (NHSN)

NHSN subject matter experts have created training videos for 2021 NHSN updates. Recorded presentations cover the following topics:

  • LabID Analysis in Acute Care Hospitals – FAQs and Troubleshooting
  • MRSA Bacteremia and CDI LabID Event Reporting – Refresher
  • Clarifications to 2021 Bloodstream Infection Definitions
  • 2021 Secondary BSI and Chapter 17 Updates
  • Catheter-associated Urinary Tract Infection (CAUTI) – Update
  • Ventilator-associated Event (VAE) and Pediatric Ventilator-associated Event (PedVAE) Analysis
  • Surgical Site Infection (SSI) – Updates and Refresher
  • Optimizing the Group User Analysis Experience
  • NHSN Antimicrobial Resistance (AR) Option: Facility-Wide Antibiogram Report
  • Internal Data Validation
  • Healthcare Personnel Vaccination Module: Influenza Vaccination Summary Reporting for IRF Units in LTACHs and IPFs

2023 National Healthcare Safety Network (NHSN); Patient Safety Component Manual

CDC, National Healthcare Safety Network (NHSN)

The Patient Safety Component includes five modules that focus on events associated with medical devices, surgical procedures, antimicrobial agents used during healthcare, multidrug resistant organisms, and Coronavirus Infectious Disease 2019 (COVID-19).

National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination

Office of Disease Prevention and Health Promotion (ODPHP)

In recognition of health care-associated infections (HAIs) as an important public health and patient safety issue, the U.S. Department of Health and Human Services (HHS) convened the Federal Steering Committee for the Prevention of Health Care-Associated Infections (originally called the HHS Steering Committee, but was changed to reflect the addition of agencies outside of HHS). The Steering Committee’s charge is to coordinate and maximize the efficiency of prevention efforts across the federal government. Members of the Steering Committee include clinicians, scientists, and public health leaders representing: